Immunome (IMNM) Treasury Shares (2019 - 2023)

Immunome's (IMNM) quarterly Treasury Shares came in at $20834.0 in Q1 2023, down 99.63% on a QoQ basis from $5.7 million in Q3 2020.

Immunome (IMNM) Treasury Shares (2019 - 2023) Analysis & Trends

Immunome (IMNM) has 3 years of Treasury Shares data on file, last reported at $20834.0 in Q1 2023.

Quarterly Treasury Shares changed N/A year-over-year to $20834.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $20834.0 (changed N/A YoY) and the FY2019 annual result came in at $4.4 million, changed N/A from the prior year.
Treasury Shares eased to $20834.0 in Q1 2023, from $5.7 million in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $5.7 million in Q2 2020 to a low of $20834.0 in Q1 2023.
A 3-year average of $3.9 million and a median of $4.4 million in 2019 frame the typical range for Treasury Shares.
The widest YoY moves for Treasury Shares: up 82.39% in 2020, down 82.39% in 2020.
Tracing IMNM's Treasury Shares over 3 years: stood at $4.4 million in 2019, then rose by 27.61% to $5.7 million in 2020, then slumped by 99.63% to $20834.0 in 2023.
The last three Treasury Shares figures came in at $20834.0 (Q1 2023), $5.7 million (Q3 2020), and $5.7 million (Q2 2020), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Immunome	3.09 Bn	2.57 Bn	-	-

Download Data